Analgesics
Antiandrogens
Azvudine
Bromhexine
Budesonide
Colchicine
Conv. Plasma
Curcumin
Famotidine
Favipiravir
Fluvoxamine
Hydroxychlor..
Ivermectin
Lifestyle
Melatonin
Metformin
Minerals
Molnupiravir
Monoclonals
Naso/orophar..
Nigella Sativa
Nitazoxanide
Paxlovid
Quercetin
Remdesivir
Thermotherapy
Vitamins
More

Other
Feedback
Home
Top
Abstract
All remdesivir studies
Meta analysis
 
Feedback
Home
next
study
previous
study
c19early.org COVID-19 treatment researchRemdesivirRemdesivir (more..)
Melatonin Meta
Metformin Meta
Azvudine Meta
Bromhexine Meta Molnupiravir Meta
Budesonide Meta
Colchicine Meta
Conv. Plasma Meta Nigella Sativa Meta
Curcumin Meta Nitazoxanide Meta
Famotidine Meta Paxlovid Meta
Favipiravir Meta Quercetin Meta
Fluvoxamine Meta Remdesivir Meta
Hydroxychlor.. Meta Thermotherapy Meta
Ivermectin Meta

All Studies   Meta Analysis    Recent:   

Evolving Clinical Manifestations and Outcomes in COVID-19 Patients: A Comparative Analysis of SARS-CoV-2 Variant Waves in a Romanian Hospital Setting

Briciu et al., Pathogens, doi:10.3390/pathogens12121453
Dec 2023  
  Post
  Facebook
Share
  Source   PDF   All Studies   Meta AnalysisMeta
Retrospective 9,049 hospitalized COVID-19 patients in Romania showing increased risk of acute kidney injury and liver injury with remdesivir treatment.
Gérard, Wu, Zhou show significantly increased risk of acute kidney injury with remdesivir.
Briciu et al., 14 Dec 2023, retrospective, Romania, peer-reviewed, median age 61.0, 11 authors, study period 27 February, 2020 - 31 March, 2023. Contact: dleucuta@umfcluj.ro (corresponding author), briciu.tincuta@umfcluj.ro, monica.muntean@umfcluj.ro, aradulescu@umfcluj.ro, cristina.cismaru@umfcluj.ro, topan.adriana@umfcluj.ro, melinda.horvat@umfcluj.ro, mihaela.lupse@yahoo.com, herbelucia@yahoo.com, mihai_calinn@yahoo.com, roxidobrota@gmail.com.
This PaperRemdesivirAll
Evolving Clinical Manifestations and Outcomes in COVID-19 Patients: A Comparative Analysis of SARS-CoV-2 Variant Waves in a Romanian Hospital Setting
Violeta Briciu, Daniel-Corneliu Leucuta, Monica Muntean, Amanda Radulescu, Cristina Cismaru, Adriana Topan, Lucia Herbel, Melinda Horvat, Mihai Calin, Roxana Dobrota, Mihaela Lupse
Pathogens, doi:10.3390/pathogens12121453
The aim of this study was to evaluate differences in the clinical manifestations and outcomes in hospitalized patients with COVID-19 in a single Romanian center during four pandemic waves determined by different SARS-CoV-2 variants of concern (VOCs). A retrospective study on 9049 consecutive hospitalized adult patients was performed between 27 February 2020 and 31 March 2023. The study interval was divided into waves based on national data on SARS-CoV-2 VOCs' circulation. Multivariate logistic regression models were built, predicting death and complications as functions of comorbidities, therapy, wave, severity form, and vaccination status, and adjusted for ages ≥65 years. Pulmonary (pneumothorax/pneumomediastinum, pulmonary embolism) and extrapulmonary complications (liver injury, acute kidney injury, ischemic/hemorrhagic stroke, myocardial infarction, and gastrointestinal bleeding) were present, more frequently in ICU hospitalized patients and with differences between waves. The highest in-hospital mortality was found in patients presenting pneumothorax/pneumomediastinum. All of the evaluated risk factors were significantly associated with death, except for obesity and the Omicron wave. Our study highlights the changing nature of COVID-19 and acknowledges the impacts of viral mutations on disease outcomes. For all four waves, COVID-19 was a severe disease with a high risk of poor outcomes.
Conflicts of Interest: The authors declare no conflict of interest.
References
Al Ghamdi, Alqahtani, Al Dajani, Alsaedi, Al-Rubaish et al., Pneumothorax in Critically Ill COVID-19 Patients: Prevalence, Analysis of Risk Factors and Clinical Outcomes, Int. J. Gen. Med, doi:10.2147/IJGM.S387868
Ashktorab, Russo, Oskrochi, Latella, Massironi et al., Clinical and endoscopic outcomes in coronavirus disease-2019 patients with gastrointestinal bleeding, Gastro Hep Adv, doi:10.1016/j.gastha.2022.02.021
Bavishi, Bonow, Trivedi, Abbott, Messerli et al., Special Article-Acute myocardial injury in patients hospitalized with COVID-19 infection: A review, Prog. Cardiovasc. Dis, doi:10.1016/j.pcad.2020.05.013
Beghi, Giussani, Westenberg, Allegri, Garcia-Azorin et al., Acute and post-acute neurological manifestations of COVID-19: Present findings, critical appraisal, and future directions, J. Neurol, doi:10.1007/s00415-021-10848-4
Bie Ńkowski, Kowalska, Paciorek, Wasilewski, Uliczny et al., The Clinical Course and Outcomes of Patients Hospitalized Due to COVID-19 during Three Pandemic Waves in Poland: A Single Center Observational Study, J. Clin. Med, doi:10.3390/jcm11247386
Briciu, Topan, Calin, Dobrota, Leucuta et al., Comparison of COVID-19 Severity in Vaccinated and Unvaccinated Patients during the Delta and Omicron Wave of the Pandemic in a Romanian Tertiary Infectious Diseases Hospital, Healthcare, doi:10.3390/healthcare11030373
Cappell, Friedel, Gastrointestinal Bleeding in COVID-19-Infected Patients, Gastroenterol. Clin. N. Am, doi:10.1016/j.gtc.2022.10.004
Core, R: A Language and Environment for Statistical Computing
Elshazli, Kline, Elgaml, Aboutaleb, Salim et al., Gastroenterology manifestations and COVID-19 outcomes: A meta-analysis of 25,252 cohorts among the first and second waves, J. Med. Virol, doi:10.1002/jmv.26836
Garcia, Dehghani, Stanberry, Grines, Patel et al., Trends in clinical presentation, management, and outcomes of STEMI in patients with COVID-19, J. Am. Coll. Cardiol, doi:10.1016/j.jacc.2022.03.345
Guo, Fan, Chen, Wu, Zhang et al., Cardiovascular Implications of fatal outcomes of patients with Coronavirus disease 2019 (COVID-19), JAMA Cardiol, doi:10.1001/jamacardio.2020.1017
King, Vail, O'leary, Hannan, Brough et al., Anakinra in COVID-19: Important considerations for clinical trials, Lancet Rheumatol, doi:10.1016/S2665-9913(20)30160-0
Kurata, Miyayama, Ogawa, Watanabe, Asano et al., Thromboembolic events in hospitalised patients with COVID-19: Ecological assessment with a scoping review, BMJ Open, doi:10.1136/bmjopen-2022-066218
Labenz, Toenges, Wörns, Sprinzl, Galle et al., Liver injury in patients with severe acute respiratory syndrome coronavirus-2 infection: A systematic review and meta-analysis, Eur. J. Gastroenterol. Hepatol, doi:10.1097/MEG.0000000000001827
Legislativ, Protocol of Treatment of SARS-CoV-2 Infection
Liatsos, SARS-CoV-2 induced liver injury: Incidence, risk factors, impact on COVID-19 severity and prognosis in different population groups, World J. Gastroenterol, doi:10.3748/wjg.v29.i16.2397
Louis, Saad, Vijayakumar, Ilyas, Kokkirala et al., The Cardiovascular Manifestations of COVID-19, Heart Fail Clin, doi:10.1016/j.hfc.2022.08.001
Mallhi, Khan, Adnan, Stratification of Acute Kidney Injury in COVID-19, Am. J. Trop. Med. Hyg, doi:10.4269/ajtmh.20-0794
Margos, Meintanopoulos, Filioglou, Ellul, Intracerebral hemorrhage in COVID-19: A narrative review, J. Clin. Neurosci, doi:10.1016/j.jocn.2021.05.019
Matsumoto, Prowle, COVID-19-associated AKI, Curr. Opin. Crit. Care, doi:10.1097/MCC.0000000000000988
Matsuoka, Koami, Shinada, Sakamoto, Investigation of differences in coagulation characteristics between hospitalized patients with SARS-CoV-2 Alpha, Delta, and Omicron variant infection using rotational thromboelastometry (ROTEM): Asinglecenter, retrospective, observational study, J. Clin. Lab. Anal, doi:10.1002/jcla.24796
Mărcău, Purec, Niculescu, Study on the Refusal of Vaccination against COVID-19 in Romania, Vaccines, doi:10.3390/vaccines10020261
Nannoni, De Groot, Bell, Markus, Stroke in COVID-19: A systematic review and meta-analysis, Int. J. Stroke, doi:10.1177/1747493020972922
Negro, Villa, Rolandi, Lucchini, Bambi, Gastrointestinal Bleeding in COVID-19 Patients: A Rapid Review, Gastroenterol. Nurs, doi:10.1097/SGA.0000000000000676
Noble, Selby, The Changing Nature of COVID-19-Associated AKI: Where Are We Now?, Nephrol. Dial. Transpl, doi:10.1093/ndt/gfab326
Ousseiran, Fares, Chamoun, Neurological manifestations of COVID-19: A systematic review and detailed comprehension, Int. J. Neurosci, doi:10.1080/00207454.2021.1973000
Radulescu, Istrate, Flonta, Lupse, Antibody and viral RNA kinetics in SARS-CoV2 infected patients admitted to a Romanian University Hospital of Infectious Diseases, Int. J. Infect. Dis, doi:10.1016/j.ijid.2021.04.067
Radulescu, Istrate, Muntean, Treatment with Tocilizumab in Adult Patients with Moderate to Critical COVID-19 Pneumonia: A Single-Center Retrospective Study, Int. J. Infect. Dis, doi:10.1016/j.ijid.2022.01.048
Redruello-Guerrero, Ruiz-Del-Pino, Jiménez-Gutiérrez, Jiménez-Gutiérrez, Carrascos-Cáliz et al., COVID-19-associated lung weakness (CALW): Systematic review and meta-analysis, Med. Intensiv, doi:10.1016/j.medine.2023.06.001
Salahuddin, Afreen, Sheikh, Lateef, Dawod et al., Neurological predictors of clinical outcomes in hospitalized patients with COVID-19, Front. Neurol, doi:10.3389/fneur.2020.585944
Shams, Kazemi, Jafaryan, Morowvat, Peymani et al., Acute kidney injury in COVID-19 patients receiving remdesivir: A systematic review and meta-analysis of randomized clinical trials, Clinics, doi:10.1016/j.clinsp.2023.100200
Sullivan, Lees, Drake, Docherty, Oates et al., Acute kidney injury in patients hospitalized with COVID-19 from the ISARIC WHO CCP-UK Study: A prospective, multi-centre cohort study, Nephrol. Dial. Transplant, doi:10.1093/ndt/gfab303
Wu, Luo, Wu, He, Li et al., Acute kidney injury associated with remdesivir: A comprehensive pharmacovigilance analysis of COVID-19 reports in FAERS, Front. Pharmacol, doi:10.3389/fphar.2022.692828
Zellmer, Hanses, Muzalyova, Classen, Braun et al., Gastrointestinal bleeding and endoscopic findings in critically and non-critically ill patients with corona virus disease 2019 (COVID-19): Results from Lean European Open Survey on SARS-CoV-2 (LEOSS) and COKA registries, United Eur. Gastroenterol. J, doi:10.1002/ueg2.12165
Late treatment
is less effective
Please send us corrections, updates, or comments. c19early involves the extraction of 100,000+ datapoints from thousands of papers. Community updates help ensure high accuracy. Vaccines and treatments are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment, vaccine, or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop   
Submit